Glucose Health, Inc.
GLUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $384 | $535 | $1,073 | $954 |
| % Growth | -28.2% | -50.1% | 12.5% | – |
| Cost of Goods Sold | $309 | $319 | $616 | $544 |
| Gross Profit | $76 | $216 | $457 | $410 |
| % Margin | 19.7% | 40.3% | 42.6% | 43% |
| R&D Expenses | $6 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $139 |
| SG&A Expenses | $377 | $638 | $1,019 | $334 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $184 |
| Other Operating Expenses | $0 | $0 | $0 | $412 |
| Operating Expenses | $382 | $638 | $1,019 | $746 |
| Operating Income | -$307 | -$422 | -$562 | -$336 |
| % Margin | -79.8% | -78.9% | -52.4% | -35.2% |
| Other Income/Exp. Net | -$9 | $0 | $0 | -$3 |
| Pre-Tax Income | -$316 | -$422 | -$562 | -$339 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$316 | -$422 | -$562 | -$339 |
| % Margin | -82.3% | -78.9% | -52.4% | -35.5% |
| EPS | -0.025 | -0.029 | -0.045 | -0.026 |
| % Growth | 13.9% | 35.2% | -72.6% | – |
| EPS Diluted | -0.025 | -0.029 | -0.045 | -0.026 |
| Weighted Avg Shares Out | 17,025 | 17,003 | 14,493 | 12,877 |
| Weighted Avg Shares Out Dil | 17,025 | 17,003 | 14,493 | 12,877 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $9 | $0 | $0 | $3 |
| Depreciation & Amortization | $1 | $168 | $228 | $0 |
| EBITDA | -$305 | -$422 | -$562 | -$336 |
| % Margin | -79.5% | -78.9% | -52.4% | -35.2% |